FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

32237311000001100: Osimertinib mesylate (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    96966401000001110 Osimertinib mesylate (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    96966501000001114 Osimertinib mesylate en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Osimertinib mesylate Is a Osimertinib false Inferred relationship Existential restriction modifier
    Osimertinib mesylate Is a Osimertinib false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Osimertinib 80mg tablets Has specific active ingredient False Osimertinib mesylate Inferred relationship Existential restriction modifier
    Tagrisso 80mg tablets (AstraZeneca UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Osimertinib mesylate Inferred relationship Existential restriction modifier
    Osimertinib 80mg tablets 30 tablet Has specific active ingredient False Osimertinib mesylate Inferred relationship Existential restriction modifier
    Tagrisso 80mg tablets (AstraZeneca UK Ltd) Has specific active ingredient False Osimertinib mesylate Inferred relationship Existential restriction modifier
    Tagrisso 40mg tablets (AstraZeneca UK Ltd) Has specific active ingredient False Osimertinib mesylate Inferred relationship Existential restriction modifier
    Osimertinib 40mg tablets 30 tablet Has specific active ingredient False Osimertinib mesylate Inferred relationship Existential restriction modifier
    Osimertinib 40mg tablets Has specific active ingredient False Osimertinib mesylate Inferred relationship Existential restriction modifier
    Tagrisso 40mg tablets (AstraZeneca UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Osimertinib mesylate Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start